Clinical Trial Update: EYP001a Food Effect Study in Subjects With Chronic Hepatitis B Virus (HBV) Infection [Phase 1]

View source ↗

Summary

Phase 1 food-effect study of EYP001a in adults with chronic hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• EYP001a (EYP001a)

Snippet

Sponsor: Enyo Pharma | Conditions: Hepatitis B, Chronic | Phase 1 | Status: COMPLETED